Skip to main content
SpringerLink
Log in

Quality of Life Issues for Patients with Cirrhosis

  • Chapter
  • First Online:
Complications of Cirrhosis

Abstract

Health-related quality of life (HRQOL) is one of the most important patient-reported outcomes that has gained increasing importance in today’s health-care environment, especially, when assessing the impact of a chronic disease or its treatment. Chronic conditions such as liver disease and cirrhosis have significant negative impact on a patient’s HRQOL. Additionally, their treatment can further impact patients’ well-being. This chapter reviews the current measurement tools used to measure HRQOL in patients with cirrhosis as well as offering the reader a brief HRQOL update for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kondo Y, Yoshida H, Tateishi R, Shiina S, Mine N, Yamashiki N, Sato S, Kato N, Kanai F, Yanase M, Yoshida H, Akamatsu M, Teratani T. Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma. J Gastroenterol Hepatol. 2007;22(2):197–203.

    Article  PubMed  Google Scholar 

  2. van der Plas SM, Hansen BE, de Boer JB, Stijnen T, Passchier J, de Man RA, Schalm SW. Generic and disease-specific health related quality of life of liver patients with various aetiologies: a survey. Qual Life Res. 2007;16(3):375–88.

    Article  Google Scholar 

  3. Sobhonslidsuk A, Silpakit C, Kongsakon R, Satitpornkul P, Sripetch C, Khanthavit A. Factors influencing health-related quality of life in chronic liver disease. World J Gastroenterol. 2006;12(48):7786–91.

    PubMed Central  PubMed  Google Scholar 

  4. Gutteling JJ, de Man RA, van der Plas SM, Schalm SW, Busschbach JJ, Darlington AS. Determinants of quality of life in chronic liver patients. Aliment Pharmacol Ther. 2006;23(11):1629–35.

    Article  CAS  PubMed  Google Scholar 

  5. The Health Measurement Research Group. Health related quality of life tools. Obtained from the world wide web at: http://www.healthmeasurement.org/Measures.html. Accessed 16 April 2014.

  6. Quality Metrics. Hepatitis Quality of Life Questionnaire (HQLQv2). Obtained from the world wide web at: http://www.qualitymetric.com/WhatWeDo/DiseasespecificHealthSurveys/HepatitisQualityofLifeQuestionnaireHQLQv2/tabid/193/Default.aspx. Accessed 15 April 2014.

  7. Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45(2):295–300.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, Marchesini G, Younossi ZM. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther. 2009;30(5):469–76.

    Article  CAS  PubMed  Google Scholar 

  9. Solà E1, Watson H, Graupera I, Turón F, Barreto R, Rodríguez E, Pavesi M, Arroyo V, Guevara M, Ginès P. Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. J Hepatol. 2012;57(6):1199–206. doi:10.1016/j.jhep.2012.07.020. Epub 2012 Jul 20.

    Google Scholar 

  10. Les I, Doval E, Flavià M, Jacas C, Cárdenas G, Esteban R, Guardia J, Córdoba J. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol. 2010;22(2):221–7. doi:10.1097/MEG.0b013e3283319975.

    Article  PubMed  Google Scholar 

  11. van der Plas SM1, Hansen BE, de Boer JB, Stijnen T, Passchier J, de Man RA, Schalm SW. The liver disease symptom index 2.0; validation of a disease-specific questionnaire. Qual Life Res. 2004;13(8):1469–81.

    Article  PubMed  Google Scholar 

  12. De Bruin A, Diederiks J, De Witte L, Stevens F, Philipsen H. The development of a short generic version of the sickness impact profile. J Clin Epidemiol. 1994;47:407–12.

    Article  CAS  PubMed  Google Scholar 

  13. Two R1, Verjee-Lorenz A, Clayson D, Dalal M, Grotzinger K, Younossi ZM. A methodology for successfully producing global translations of patient reported outcome measures for use in multiple countries. Value Health. 2010;13(1):128–31. doi:10.1111/j.1524-4733.2009.00585.x. Epub 2009 Aug 20.

    Google Scholar 

  14. Centers for Disease Control—Health Related Quality of Life. Obtained from the world wide web at http://www.cdc.gov/HRQoL/concept.htm. Accessed 15 April 2014.

  15. Gnanasakthy A, Mordin M, Clark M, DeMuro C, Fehnel S, Copley-Merriman C. A review of patient-reported outcome labels in the United States: 2006–2010. Value Health. 2012;15(3):437–42.

    Article  PubMed  Google Scholar 

  16. Loria A, Escheik C, Gerber NL, Younossi ZM. Quality of life in cirrhosis. Curr Gastroenterol Rep. 2013 Jan;15(1):301. doi:10.1007/s11894-012-0301-5. Review.

    Article  PubMed  Google Scholar 

  17. Loria A, Doyle K, Weinstein AA, Winter P, Escheik C, Price J, Wang L, Birerdinc A, Baranova A, Gerber L, Younossi ZM. Multiple factors predict physical performance in people with chronic liver disease. Am J Phys Med Rehabil. 2014 Jan 6;93(6):470-6. (Epub ahead of print).

    Google Scholar 

  18. Younossi ZM. Chronic liver disease and health-related quality of life. Gastroenterology. 2001 Jan;120(1):305–7.

    Article  CAS  PubMed  Google Scholar 

  19. Afendy A1, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, Marchesini G, Younossi ZM. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther. 2009 Sep 1;30(5):469–76. doi:10.1111/j.1365-2036.2009.04061.x. Epub 2009 Jun 9.

    Google Scholar 

  20. Younossi Z, Stepanova M, Henry L, Gane E, et al. Sof paper effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C. Obtained from the world wide web at http://www.cghjournal.org/search/quick?restrictName.yjcgh=yjcgh&search_area=journal&search_text1=CLDQ-HCV. Accessed 14 April 2014.

  21. Gutteling JJ, Duivenvoorden HJ, Busschbach JJ, de Man RA, Darlington AS. Psychological determinants of health-related quality of life in patients with chronic liver disease. Psychosomatics. 2010;51(2):157–65.

    Article  PubMed  Google Scholar 

  22. Gutteling JJ, de Man RA, Busschbach JJ, Darlington AS. Overview of research on health-related quality of life in patients with chronic liver disease. Neth J Med. 2007;65(7):227–34.

    CAS  PubMed  Google Scholar 

  23. Loria A, Escheik C, Gerber NL, Younossi ZM. Quality of life in cirrhosis. Curr Gastroenterol Rep. 2012;15:301.

    Article  Google Scholar 

  24. Häuser W, Holtmann G, Grandt D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol. 2004;2(2):157–63.

    Article  PubMed  Google Scholar 

  25. Les I, Doval E, Flavià M, Jacas C, Cárdenas G, Esteban R, Guardia J, Córdoba J. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol. 2010;22(2):221–7. doi:10.1097/MEG.0b013e3283319975.

    Article  PubMed  Google Scholar 

  26. Escheik C, Gerber L, Rover L, Arsalla Z, Otgonsuren M, Younossi ZM. Validation of CLDQ-HCV as a Health Related Quality of Life (HRQOL) instrument for patients with Chronic Hepatitis C (CH-C). Presented at Program No. P240. ACG 2012 Annual Scientific Meeting Abstracts. Las Vegas, NV: American College of Gastroenterology. Accessed from the world wide web at: http://www.eventscribe.com/2012/acg/ajaxcalls/postersinfo.asp?title=7565. Accessed 14 April 2014.

  27. Bao ZJ, Qiu DK, Ma X, et al. Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy. World J Gastroenterol. 2007;13:3003–8.

    PubMed Central  PubMed  Google Scholar 

  28. Ferrer M, Cordoba J, Garin O, Olive G, Flavia M, Vargas V, Esteban R, Alonso J. Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transplant. 2006;12(1):95–104.

    Article  Google Scholar 

  29. Kanwal F, Spiegel BM, Hays RD, Durazo F, Han SB, Saab S, Bolus R, Kim SJ, Gralnek IM. Prospective validation of the short form liver disease quality of life instrument. Aliment Pharmacol Ther. 2008;28(9):1088–101.

    Article  CAS  PubMed  Google Scholar 

  30. Sobhonslidsuk A, Silpakit C, Kongsakon R, Satitpornkul P, Sripetch C. Chronic liver disease questionnaire: translation and validation in Thais. World J Gastroenterol. 2004;10(13):1954–7.

    PubMed  Google Scholar 

  31. Hauser W, Schnur M, Steder-Neukamm U, Muthny FA, Grandt D. Validation of the German version of the Chronic Liver Disease Questionnaire. Eur J Gastroenterol Hepatol. 2004;16(6):599–606.

    Article  PubMed  Google Scholar 

  32. Atiq M, Gill ML, Khokhar N. Quality of life assessment in Pakistani patients with chronic liver disease. J Pak Med Assoc. 2004;54(3):113–5.

    CAS  PubMed  Google Scholar 

  33. Younossi ZM, Stepanova M, Henry L, Gane E, Jacobson IM, Lawitz E, Nelson D, Gerber L, Nader F, Hunt S. Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2013 Dec 5;12(8):1349-59.e13. doi:10.1016/j.cgh.2013.11.032.

    Google Scholar 

  34. Younossi ZM, Stepanova M, Henry L, Gane E, Jacobson IM, Lawitz E, Nelson D, Nader F, Hunt S. Minimal impact of sofosbuvir and ribavirin on health related quality of life in Chronic Hepatitis C (CH-C). J Hepatol. 2013 Dec 10;60(4):741-7. doi:10.1016/j.jhep.2013.12.006.

    Google Scholar 

  35. Younossi ZM1, McCormick M, Price LL, Boparai N, Farquhar L, Henderson JM, Guyatt G. Impact of liver transplantation on health-related quality of life. Liver Transpl. 2000;6(6):779–83.

    Article  CAS  PubMed  Google Scholar 

  36. Togashi J, Sugawara Y, Akamatsu N, Tamura S, Yamashiki N, Kaneko J, Sakamoto Y, Aoki T, Hasegawa K, Kokudo N. Quality of life after adult living donor liver transplantation: a longitudinal prospective follow-up study. Hepatol Res. 2013;43:10.

    Google Scholar 

  37. Urano E, Yamanaka-Okumura H, Teramoto A, Sugihara K, Morine Y, Imura S, Utsunomiya T, Shimada M, Takeda E. Pre- and postoperative nutritional assessment and health-related quality of life in recipients of living donor liver transplantation. Hepatol Res. 2014;44:3.

    Article  Google Scholar 

  38. Neuberger J. What is the real gain after liver transplantation? Liver Transplant. 2009;15(Suppl 2):S1–5.

    Article  Google Scholar 

  39. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transplant. 2004;10:886–97.

    Article  Google Scholar 

  40. Carbone M1, Bufton S, Monaco A, Griffiths L, Jones DE, Neuberger JM. The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study. J Hepatol. 2013;59(3):490–4. doi:10.1016/j.jhep.2013.04.017. Epub 2013 Apr 27.

    Article  PubMed  Google Scholar 

  41. Sanyal A1, Younossi ZM, Bass NM, Mullen KD, Poordad F, Brown RS, Vemuru RP, Mazen Jamal M, Huang S, Merchant K, Bortey E, Forbes WP. Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy—a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2011;34(8):853–61. doi:10.1111/j.1365-2036.2011.04808.x. Epub 2011 Aug 17.

    Article  CAS  PubMed  Google Scholar 

  42. Company L, Zapater P, Perez-Mateo M, Jover R. Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2010;22:519–25.

    Article  PubMed  Google Scholar 

  43. Arguedas MR1, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci. 2003;48(8):1622–6.

    Article  PubMed  Google Scholar 

  44. Moscucci F1, Nardelli S, Pentassuglio I, Pasquale C, Ridola L, Merli M, Riggio O. Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients. Liver Int. 2011;31(10):1505–10. doi:10.1111/j.1478-3231.2011.02598.x. Epub 2011 Aug 15.

    Article  PubMed  Google Scholar 

  45. Wang JY1, Zhang NP, Chi BR, et al. Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China. World J Gastroenterol. 2013;19(30):4984–91. doi:10.3748/wjg.v19.i30.4984.

    Article  PubMed Central  PubMed  Google Scholar 

  46. Marchesini G1, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, Loguercio C, Apolone G, Niero M, Abbiati R; Italian Study Group for quality of life in cirrhosis. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120(1):170–8.

    Article  CAS  PubMed  Google Scholar 

  47. Kanwal F, Gralnek IM, Hays RD, Zeringue A, Durazo F, Han SB, Saab S, Bolus R, Spiegel BM. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol. 2009;7(7):793–9.

    Article  PubMed  Google Scholar 

  48. Mostacci B, Ferlisi M, Baldi Antognini A, Sama C, Morelli C, Mondini S, Cirignotta F. Sleep disturbance and daytime sleepiness in patients with cirrhosis: a case control study. Neurol Sci. 2008;29(4):237–40.

    Article  PubMed  Google Scholar 

  49. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–21.

    Article  PubMed  Google Scholar 

  50. Stewart CA, Malinchoc M, Kim WR, Kamath P. Hepatic encephalopathy as a predictor of survival in patients with endstage liver disease. Liver Int. 2009;29:1365–71.

    Article  Google Scholar 

  51. Bhogal HK1, Sanyal AJ. Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin Gastroenterol Hepatol. 2011;9(11):936–46; quiz e123. doi:10.1016/j.cgh.2011.06.013. Epub 2011 Jun 21.

    Article  PubMed Central  PubMed  Google Scholar 

  52. Albillos A1, Bañares R, González M, Catalina MV, Molinero LM. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol. 2005;43(6):990–6. Epub 2005 Jul 5.

    Article  PubMed  Google Scholar 

  53. Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology. 2005;41(4):790–800.

    Article  PubMed  Google Scholar 

  54. Dan AA, Crone C, Wise TN, Martin LM, Ramsey L, Magee S, Sjogren R, Ong JP, Younossi ZM. Anger experiences among hepatitis C patients: relationship to depressive symptoms and health-related quality of life. Psychosomatics. 2007;48(3):223–9.

    Article  PubMed  Google Scholar 

  55. Kallman J, O’Neil MM, Larive B, Boparai N, Calabrese L, Younossi ZM. Fatigue and health-related quality of life (HRQOL) in chronic hepatitis C virus infection. Dig Dis Sci. 2007;52(10):2531–9. Epub 2007 Apr 4.

    Article  PubMed  Google Scholar 

  56. Younossi Z, Kallman J, Kincaid J. The effects of HCV infection and management on health-related quality of life. Hepatology. 2007;45(3):806–16.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA

    Zobair M. Younossi MD, MPH

  2. Betty and Guy Beatty Center for Integrated Research, Inova Health System, Claude Moore Health Education and Research Building, 3300 Gallows Road, 22042, Falls Church, VA, USA

    Linda Henry PhD

Authors
  1. Zobair M. Younossi MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Linda Henry PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zobair M. Younossi MD, MPH .

Editor information

Editors and Affiliations

  1. Department of Transplant, Mayo Clinic, Jacksonville, Florida, USA

    Andrew P. Keaveny

  2. Institut de Malalties Digestives i Metaboliques, University of Barcelona, Barcelona, Spain

    Andrés Cárdenas

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Younossi, Z., Henry, L. (2015). Quality of Life Issues for Patients with Cirrhosis. In: Keaveny, A., Cárdenas, A. (eds) Complications of Cirrhosis. Springer, Cham. https://doi.org/10.1007/978-3-319-13614-1_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-13614-1_34

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-13613-4

  • Online ISBN: 978-3-319-13614-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation